Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, the rest of North America, the United Kingdom, the rest of Europe, and internationally. The company is headquartered in Englewood, Colorado.
| Revenue (TTM) | $1.78B |
| Gross Profit (TTM) | $492.40M |
| EBITDA | $199.60M |
| Operating Margin | 10.30% |
| Return on Equity | 9.15% |
| Return on Assets | 5.47% |
| Revenue/Share (TTM) | $71.46 |
| Book Value | $53.52 |
| Price-to-Book | 1.39 |
| Price-to-Sales (TTM) | 1.02 |
| EV/Revenue | 0.898 |
| EV/EBITDA | 7.99 |
| Quarterly Earnings Growth (YoY) | -60.90% |
| Quarterly Revenue Growth (YoY) | -2.40% |
| Shares Outstanding | $24.89M |
| Float | $24.47M |
| % Insiders | 1.33% |
| % Institutions | 100.05% |